{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_000345.3:c.137G>A",
          "cDNA Change": {
            "transcript": "NM_000345.3",
            "ref": "G",
            "alt": "A",
            "position": "137"
          },
          "Protein Change": {
            "ref": "E",
            "alt": "K",
            "position": "46"
          },
          "Description in input context": "E46K mutation"
        }
      ]
    },
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_000345.3:c.159G>C",
          "cDNA Change": {
            "transcript": "NM_000345.3",
            "ref": "G",
            "alt": "C",
            "position": "159"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "T",
            "position": "53"
          },
          "Description in input context": "A53T mutation"
        }
      ]
    },
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_000345.3:c.249A>T",
          "cDNA Change": {
            "transcript": "NM_000345.3",
            "ref": "A",
            "alt": "T",
            "position": "249"
          },
          "Protein Change": {
            "ref": "E",
            "alt": "K",
            "position": "83"
          },
          "Description in input context": "E83K mutation"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0016832"
  },
  "Experiment Method": [
    {
      "Assay Method": "Thioflavin T Fluorescence Assay",
      "Material used": {
        "Material Source": "Recombinant protein",
        "Material Name": "α-synuclein mutants and wild-type",
        "Description": "Experiments conducted using recombinant α-synuclein proteins."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000345.3:c.137G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Increased aggregation propensity",
          "Result Description": "E46K mutant showed accelerated fibrillation kinetics."
        },
        {
          "Variant": "NM_000345.3:c.159G>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Altered amyloid structure",
          "Result Description": "A53T mutant exhibited different fibril morphologies."
        },
        {
          "Variant": "NM_000345.3:c.249A>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduced aggregation",
          "Result Description": "E83K mutant displayed slower polymerization rates."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three independent experiments performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample analyzed in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type α-synuclein used as positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Buffer-only samples used as negative controls."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "1"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA used for statistical comparison."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Fluorescence intensity within wild-type range.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Significantly higher or lower fluorescence compared to wild-type.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}